secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK:        0000882796
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001171843-25-001231
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioCryst CFO Anthony Doyle to resign effective April 9, 2025; search underway
-----------------------------------------------------------------------------

- Anthony Doyle notified resignation as CFO effective April 9, 2025.
- Resignation is not due to any disagreement with the company.
- Company has initiated a search for a new CFO; Doyle will remain to assist transition.
- Doyle joined in April 2020, helped launch ORLADEYO and strengthen financial position.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882796/000117184325001231/0001171843-25-001231-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882796/000117184325001231/f8k_030425.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001231

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer